Mammalian target of rapamycin coordinates iron metabolism with iron-sulfur cluster assembly enzyme and tristetraprolin

Nutrition

Volumn 30, Issue 9, 2014, Pages 968-974

  Guan, Peng ^a   Wang, Na ^a,b  

^a HEBEI NORMAL UNIVERSITY   (China)

^b HEBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Iron; Iron sulfur clusters; Rapamycin; Transferrin receptor; Tristetraprolin

Indexed keywords

CD71 ANTIGEN; DEFEROXAMINE; FERROPORTIN; HEPCIDIN; IRON REGULATORY FACTOR; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; IRON SULFUR PROTEIN; ISCU PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MESSENGER RNA; RAPAMYCIN; SCAFFOLD PROTEIN; TRISTETRAPROLIN; UNCLASSIFIED DRUG; IRON; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MTOR PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; SULFUR; TARGET OF RAPAMYCIN KINASE;

GENE EXPRESSION; GENE REGULATORY NETWORK; HUMAN; INTRACELLULAR SIGNALING; IRON BALANCE; IRON CHELATION; IRON DEFICIENCY; IRON METABOLISM; IRON OVERLOAD; IRON RESPONSIVE ELEMENT; IRON THERAPY; LEUKEMIA CELL LINE; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; TFR1 GENE; TTP GENE; ANIMAL; HOMEOSTASIS; IRON METABOLISM DISORDER; METABOLISM;

MAMMALIA; MUS;

ANIMALS; HOMEOSTASIS; HUMANS; IRON; IRON METABOLISM DISORDERS; IRON-SULFUR PROTEINS; MULTIPROTEIN COMPLEXES; SULFUR; TOR SERINE-THREONINE KINASES; TRISTETRAPROLIN;

EID: 84905564011     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.12.016     Document Type: Review

References (41)

1. Muckenthaler M.U., Galy B., Hentze M.W. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Ann Rev Nutr 2008, 28:197-213.
2. Lee P.L., Beutler E. Regulation of hepcidin and iron-overload disease. Ann Rev Pathol 2009, 4:489-515.
3. Volz K. The functional duality of iron regulatory protein 1. Curr Opin Struct Biol 2008, 18:106-111.
4. Guo B., Yu Y., Leibold E.A. Iron regulates cytoplasmic levels of a novel iron-responsive element-binding protein without aconitase activity. J Biol Chem 1994, 269:24252-24260.
5. Hanson E.S., Rawlins M.L., Leibold E.A. Oxygen and iron regulation of iron regulatory protein 2. J Biol Chem 2003, 278:40337-40342.
6. Ke Y., Wu J., Leibold E.A., Walden W.E., Theil E.C. Loops and bulge/loops in iron-responsive element isoforms influence iron regulatory protein binding. Fine-tuning of mRNA regulation?. J Biol Chem 1998, 273:23637-23640.
7. Wallander M.L., Leibold E.A., Eisenstein R.S. Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochim Biophys Acta 2006, 1763:668-689.
8. Fleming M.D. The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematology Am Soc Hematol Educ Program 2008, 151-158.
9. Bayeva M., Khechaduri A., Puig S., Chang H.C., Patial S., Blackshear P.J., et al. mTOR regulates cellular iron homeostasis through tristetraprolin. Cell Metab 2012, 16:645-657.
10. Lamming D.W., Ye L., Sabatini D.M., Baur J.A. Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Investig 2013, 123:980-989.
11. Malik A.R., Urbanska M., Macias M., Skalecka A., Jaworski J. Beyond control of protein translation: what we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR). Biochim Biophys Acta 2013, 1834:1434-1448.
12. Tong W.H., Rouault T.A. Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. Cell Metab 2006, 3:199-210.
13. Alers S., Loffler A.S., Wesselborg S., Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 2012, 32:2-11.
14. Foster D.A. Regulation of mTOR by phosphatidic acid?. Cancer Res 2007, 67:1-4.
15. Lamming D.W., Sabatini D.M. A central role for mTOR in lipid homeostasis. Cell Metab 2013, 18:465-469.
16. Dunlop E.A., Tee A.R. Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cell Signal 2009, 21:827-835.
17. Ndong M., Kazami M., Suzuki T., Uehara M., Katsumata S., Inoue H., et al. Iron deficiency down-regulates the Akt/TSC1-TSC2/mammalian target of rapamycin signaling pathway in rats and in COS-1 cells. Nutr Res 2009, 29:640-647.
18. Ohyashiki J.H., Kobayashi C., Hamamura R., Okabe S., Tauchi T., Ohyashiki K. The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1. Cancer Sci 2009, 100:970-977.
19. Fretham S.J., Carlson E.S., Georgieff M.K. Neuronal-specific iron deficiency dysregulates mammalian target of rapamycin signaling during hippocampal development in nonanemic genetic mouse models. J Nutr 2013, 143:260-266.
20. Galvez T., Teruel M.N., Heo W.D., Jones J.T., Kim M.L., Liou J., et al. siRNA screen of the human signaling proteome identifies the PtdIns(3,4,5)P3-mTOR signaling pathway as a primary regulator of transferrin uptake. Genome Biol 2007, 8:R142.
21. La P., Yang G., Dennery P.A. Mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation stabilizes ISCU protein: implications for iron metabolism. J Biol Chem 2013, 288:12901-12909.
22. Leppanen T., Jalonen U., Korhonen R., Tuominen R.K., Moilanen E. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages. Eur J Pharmacol 2010, 628:220-225.
23. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Phillips R.S., Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 1999, 19:4311-4323.
24. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996, 4:445-454.
25. Clement S.L., Scheckel C., Stoecklin G., Lykke-Andersen J. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol Cell Biol 2011, 31:256-266.
26. Aisen P. Transferrin receptor 1. The Int J Biochem Cell Biol 2004, 36:2137-2143.
27. Howell J.J., Manning B.D. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab 2011, 22:94-102.
28. Kim M.J., Mayr M., Pechula M., Steiger J., Dickenmann M. Marked erythrocyte microcytosis under primary immunosuppression with sirolimus. Transpl Int 2006, 19:12-18.
29. Sofroniadou S., Kassimatis T., Goldsmith D. Anaemia, microcytosis and sirolimus-is iron the missing link?. Nephrol Dial Transplant 2010, 25:1667-1675.
30. Przybylowski P., Malyszko J.S., Macdougall I.C., Malyszko J. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin. Transplant Proc 2013, 45:387-390.
31. Li K., Tong W.H., Hughes R.M., Rouault T.A. Roles of the mammalian cytosolic cysteine desulfurase, ISCS, and scaffold protein, ISCU, in iron-sulfur cluster assembly. J Biol Chem 2006, 281:12344-12351.
32. Kaplan J., McVey Ward D., Crisp R.J., Philpott C.C. Iron-dependent metabolic remodeling in S. cerevisiae. Biochim Biophys Acta 2006, 1763:646-651.
33. Puig S., Askeland E., Thiele D.J. Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation. Cell 2005, 120:99-110.
34. Puig S., Vergara S.V., Thiele D.J. Cooperation of two mRNA-binding proteins drives metabolic adaptation to iron deficiency. Cell Metab 2008, 7:555-564.
35. Sims L.M., Igarashi R.Y. Regulation of the ATPase activity of ABCE1 from Pyrococcus abyssi by Fe-S cluster status and Mg(2)(+): implication for ribosomal function. Arch Biochem Biophys 2012, 524:114-122.
36. Marygold S.J., Leevers S.J. Growth signaling: TSC takes its place. Curr Biol 2002, 12:R785-R787.
37. Ballou L.M., Jiang Y.P., Du G., Frohman M.A., Lin R.Z. Ca(2+)- and phospholipase D-dependent and -independent pathways activate mTOR signaling. FEBS Lett 2003, 550:51-56.
38. Frost R.A., Lang C.H. mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong?. Physiology (Bethesda) 2011, 26:83-96.
39. Tee A.R., Blenis J., Proud C.G. Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. FEBS Lett 2005, 579:4763-4768.
40. Eisenstein R.S. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Ann Rev Nutr 2000, 20:627-662.
41. Faulk W.P., Hsi B.L., Stevens P.J. Transferrin and transferrin receptors in carcinoma of the breast. Lancet 1980, 2:390-392.